Robert Andtbacka

Robert Andtbacka, MD, CM, FACS, FRCSC, currently serves as the Chief Medical Officer at HiFiBiO Therapeutics since June 2023. Prior to this role, Andtbacka held the position of Chief Medical Officer at Seven and Eight Biopharmaceuticals Inc. from September 2018 to June 2023. Andtbacka has an extensive academic career at Huntsman Cancer Institute from 2006 to 2018, where roles included Professor of Surgery, Co-Director of Melanoma & Cutaneous Oncology, and Director of the Melanoma Clinical Research Program. Additional leadership experience includes serving as Chief Medical Officer at Vestan Inc. and working as a Flight Physician at Skyservice Lifeguard Inc. Education credentials include a Fellowship in Surgical Oncology from MD Anderson Cancer Center and multiple degrees from McGill University, culminating in a Doctor of Medicine.